Show Nav →
Please include the following statement when referencing the CPTAC Assay Portal
We would like to acknowledge the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) Assay Portal (assays.cancer.gov) for developing assays and establishing criteria for the assays described in this publication.

Overview Data source: UniProt

Official Gene Symbol Other Aliases
AMPD1 N/A
Sequence Length (AA) Molecular Weight (Da)
780 90219
Protein Name
AMP deaminase 1
Sources
UniProt
PhosphoSitePlus ®
GeneCards
Human Protein Atlas

Protein Sequence hover to view complete sequence

10 20 30 40 50
MNVRIFYSVS QSPHSLLSLL FYCAILESRI SATMPLFKLP AEEKQIDDAM
60 70 80 90 100
RNFAEKVFAS EVKDEGGRQE ISPFDVDEIC PISHHEMQAH IFHLETLSTS
110 120 130 140 150
TEARRKKRFQ GRKTVNLSIP LSETSSTKLS HIDEYISSSP TYQTVPDFQR
160 170 180 190 200
VQITGDYASG VTVEDFEIVC KGLYRALCIR EKYMQKSFQR FPKTPSKYLR
210 220 230 240 250
NIDGEAWVAN ESFYPVFTPP VKKGEDPFRT DNLPENLGYH LKMKDGVVYV
260 270 280 290 300
YPNEAAVSKD EPKPLPYPNL DTFLDDMNFL LALIAQGPVK TYTHRRLKFL
310 320 330 340 350
SSKFQVHQML NEMDELKELK NNPHRDFYNC RKVDTHIHAA ACMNQKHLLR
360 370 380 390 400
FIKKSYQIDA DRVVYSTKEK NLTLKELFAK LKMHPYDLTV DSLDVHAGRQ
410 420 430 440 450
TFQRFDKFND KYNPVGASEL RDLYLKTDNY INGEYFATII KEVGADLVEA
460 470 480 490 500
KYQHAEPRLS IYGRSPDEWS KLSSWFVCNR IHCPNMTWMI QVPRIYDVFR
510 520 530 540 550
SKNFLPHFGK MLENIFMPVF EATINPQADP ELSVFLKHIT GFDSVDDESK
560 570 580 590 600
HSGHMFSSKS PKPQEWTLEK NPSYTYYAYY MYANIMVLNS LRKERGMNTF
610 620 630 640 650
LFRPHCGEAG ALTHLMTAFM IADDISHGLN LKKSPVLQYL FFLAQIPIAM
660 670 680 690 700
SPLSNNSLFL EYAKNPFLDF LQKGLMISLS TDDPMQFHFT KEPLMEEYAI
710 720 730 740 750
AAQVFKLSTC DMCEVARNSV LQCGISHEEK VKFLGDNYLE EGPAGNDIRR
760 770 780
TNVAQIRMAY RYETWCYELN LIAEGLKSTE

Data source: UniProt


Position of Targeted Peptide Analytes Relative to SNPs, Isoforms, and PTMs

Uniprot Database Entry PhosphoSitePlus ®

Click a point on a node
to view detailed assay information below
All other points link out to UniProt



Phosphorylation Acetylation Ubiquitylation Other

loading

Loader

Assay Details for CPTAC-1752 Collapse assay details

Data source: Panorama

Official Gene Symbol
AMPD1
Peptide Sequence
TDNLPENLGYHLK
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
230
Peptide End
242
CPTAC ID
CPTAC-1752
Peptide Molecular Mass
1,512.7573
Species
Homo sapiens (Human)
Assay Type
Fractionation PRISM-SRM
Fractionation Approach
high-pressure, high-resolution, high pH reverse phase frationation with online monitoring (PRISM)
Matrix
Ovarian cancer tumor tissue lysate
Submitting Laboratory
Pacific Northwest National Laboratory
Submitting Lab PI
Tao Liu

Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
TSQ Vantage
Internal Standard
peptide
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus K
LC
Waters nanoACQUITY (Part Number 176016000)
Column Packing
Waters BEH C18, 1.7 um 130 Å (Part Number 186007485)
Column Dimensions
100 um x 100 mm
Flow Rate
0.4 (uL/min)

Assay Multiplexing Expand assay panel

Pacific Northwest National Laboratory-PRISMSRM


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y9 (2+) 8.5 5.8 11.1 10.2 7.6 14.7 13.3 9.6 18.4 15 15 15
y3 (1+) 12.2 7.3 10.4 11.1 9.4 14.6 16.5 11.9 17.9 15 15 15
y5 (1+) 5.8 2.3 3.6 5.7 5.3 11.7 8.1 5.8 12.2 15 15 15
sum 4.8 2.7 3.9 6.5 5 9.7 8.1 5.7 10.5 15 15 15


Additional Resources and Comments


Assay Details for CPTAC-1753 Collapse assay details

Data source: Panorama

Official Gene Symbol
AMPD1
Peptide Sequence
YNPVGASELR
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
412
Peptide End
421
CPTAC ID
CPTAC-1753
Peptide Molecular Mass
1,104.5564
Species
Homo sapiens (Human)
Assay Type
Fractionation PRISM-SRM
Fractionation Approach
high-pressure, high-resolution, high pH reverse phase frationation with online monitoring (PRISM)
Matrix
Ovarian cancer tumor tissue lysate
Submitting Laboratory
Pacific Northwest National Laboratory
Submitting Lab PI
Tao Liu

Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
TSQ Vantage
Internal Standard
peptide
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C and 15N at C-terminus R
LC
Waters nanoACQUITY (Part Number 176016000)
Column Packing
Waters BEH C18, 1.7 um 130 Å (Part Number 186007485)
Column Dimensions
100 um x 100 mm
Flow Rate
0.4 (uL/min)

Assay Multiplexing Expand assay panel

Pacific Northwest National Laboratory-PRISMSRM


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y8 (2+) 6.4 5.6 3.1 8.4 6.5 3 10.6 8.6 4.3 15 15 15
y6 (1+) 4.2 6.1 3.2 6 6.8 5.8 7.3 9.1 6.6 15 15 15
y8 (1+) 5.5 3.8 3 6.6 4.3 3.2 8.6 5.7 4.4 15 15 15
sum 3.2 4.4 2.2 5.5 5.4 3.2 6.4 7 3.9 15 15 15


Additional Resources and Comments